Cann Group (CAN) Short Interest
Cann Group (ASX:CAN) had 4.39% of shares reported as short positions as of 3 Dec 2025, representing 42,263,544 shares. Cann Group operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Cann Group
Cann Group is an Australian pharmaceutical company focused on cultivating cannabis for medicinal and research purposes. They manufacture medicinal cannabis products, aiming to be a national benchmark for R&D and production processes. The company strives to improve the quality of life for patients through ethical leadership in the emerging medical cannabis industry.
Short position
Cann Group (ASX:CAN) has 4.39% of its shares on issue reported as short positions as of 3 Dec 2025, or about 42,263,544 shares. Over the past 30 days that figure has risen 3.51 percentage points, and over 90 days it has risen 4.39 percentage points. CAN is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 40, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4CAN intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
CAN Short Interest History
- 30-day change
- +3.51pp
- 90-day change
- +4.39pp
- 1-year change
- +4.39pp
- All-time high
- 4.43% (December 2025)
- All-time low
- 0.00% (April 2023)
Is CAN heavily shorted?
Not especially: 4.39% short interest is modest by ASX standards. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has CAN's short interest changed recently?
Over the past 30 days Cann Group's short interest has risen 3.51 percentage points, and over 90 days it has risen 4.39 percentage points. The current level is 4.39% of shares on issue.
What is the highest CAN's short interest has been?
Since 2017, Cann Group's short interest peaked at 4.43% in December 2025 and bottomed at 0.00% in April 2023.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2017. See our methodology.
CAN fundamentals
In the year to 30 Jun 2026, Cann Group (ASX:CAN) recorded revenue of A$9.7M and net profit after tax of A$20.3M. A year earlier it recorded revenue of A$13.2M and a net loss after tax of A$22.3M. Year-on-year growth: revenue −27.1% (FY). Net margin 210.4% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit), as at 29 Sep 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Strategy fit
How each stock picker strategy reads CAN today
PassFailUnknown (data missing, or not meaningful for this company)
- Zanger Breakout
WatchScore 20rank 1202 of 1967
- 1. Explosive growth: pass. Revenue -27.1% YoY (FY ending 2026-06-30); EPS swung from a loss to a profit (FY ending 2026-06-30)
- 2. A recognisable base: fail. No tight base: 50.0% deep, deeper than 25%
- 3. Breakout on heavy volume: fail. No close above the A$0.01 pivot on 1.5x volume in the last 5 sessions; close is -33.3% from the pivot
- 4. Read the market first: fail. XJO in a downtrend: below its 200-day average
- 5. Relative strength: fail. Lagged the S&P/ASX 200 by 10.6 points over 3 months
- 6. Liquid enough to trade: fail. A$6k average daily turnover over 20 sessions, below the A$250k floor
- CAN SLIM
WatchScore 20rank 646 of 1533
- 1. Earnings growth (C and A): pass. EPS swung from a loss to a profit (FY ending 2026-06-30)
- 2. Sales growth: fail. Revenue -27.1% YoY (FY ending 2026-06-30); below the +20% threshold
- 3. New highs (N): fail. 76.5% below the 52-week high, more than 5% away
- 4. Leader, not laggard (L): fail. 6-month relative strength -34.5 points, below the top-quartile cut-off of +6.9
- 5. Market direction (M): fail. XJO in a downtrend: below its 200-day average
- 6. Supply and demand (S): fail. A$6k average daily turnover over 20 sessions, below the A$250k floor
- Minervini Trend Template
WatchScore 14rank 1234 of 1783
- 1. Above rising averages: fail. Close A$0.00, 150-day A$0.00, 200-day A$0.01: close is not above the 150-day; 150-day is not above the 200-day
- 2. 200-day trending up: fail. 200-day average A$0.01 vs A$0.01 a month ago (-8.4%): not rising
- 3. Well off the low: pass. Close A$0.00 is 100.0% above the 52-week low of A$0.00
- 4. Near the high: fail. 76.5% below the 52-week high, more than 25% away
- 5. Relative strength: fail. 6-month relative strength -34.5 points, below the top-quartile cut-off of +6.9
- 6. Above the 50-day: pass. Close A$0.00 vs 50-day average A$0.00 (+3.9%)
- 7. Liquid enough to trade: fail. A$6k average daily turnover over 20 sessions, below the A$250k floor
- Crowded-Short Breakout
WatchScore 14rank 747 of 1556
- 1. Crowded short: fail. 4.39% of shares on issue reported short, under 5%
- 2. Days to cover: pass. 12.7 days of average volume to cover
- 3. Breakout on heavy volume: fail. No close above the A$0.01 pivot on 1.5x volume in the last 5 sessions; close is -33.3% from the pivot
- 4. Market direction: fail. XJO in a downtrend: below its 200-day average
- 5. Liquid enough to trade: fail. A$6k average daily turnover over 20 sessions, below the A$250k floor
- 6. Relative strength: fail. Lagged the S&P/ASX 200 by 10.6 points over 3 months
- Quality compounders
WatchScore 15rank 963 of 1688
- 1. High return on equity: unknown. Return on equity cannot be measured: it needs net profit, equity at both ends of the year and, outside banks, insurers and other financials, equity of at least 10% of total assets
- 2. Healthy profit margin: pass. Net margin 210.4% (FY ending 2026-06-30)
- 3. Profit that turns into cash: unknown. Free cash flow or net profit is missing for the period
- 4. Little debt: unknown. Net debt cannot be measured: no aligned balance sheet with debt and cash
- 5. Liquid enough to trade: fail. A$6k average daily turnover over 20 sessions, below the A$250k floor
- 6. Long-term uptrend: fail. Close A$0.00 vs 200-day average A$0.01 (-28.2%): not above the 200-day average
- 7. Revenue not shrinking: fail. Revenue -27.1% YoY (FY ending 2026-06-30); revenue shrank
Prices to 2 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial advice
Company
AI-generated research profile of Cann Group
Latest CAN news
All news- Appendix 4G and Corporate Governance Statement
asx · 29 Sept 2026
- Annual Report to shareholders
asx · 29 Sept 2026
- Has Cann Group Reset Itself for an Export Push (ASX:CAN)?
kalkine · 25 Sept 2026
- Why Could Cann Group (ASX:CAN) Matter for Cannabis?
kalkine · 22 Sept 2026
- Why Could Cann Group (ASX:CAN) Matter for Cannabis Stocks? - Kalkine Media
googlenews · 21 Sept 2026
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss CAN
Start a research thread or post the first pulse update